Literature DB >> 2536532

Stimulation of phosphatidylinositol 4,5-bisphosphate phospholipase C activity by phosphatidic acid.

S Jackowski1, C O Rock.   

Abstract

Phosphatidic acid was a potent activator of the phosphatidylinositol 4,5-bisphosphate (PtdIns-P2) phospholipase C activity associated with human platelet membranes. Lysophosphatidic acid was half as active as phosphatidic acid, and shortening the fatty acid chain reduced the effectiveness of the corresponding phosphatidic acid. Compounds lacking either the phosphate group (diacylglycerol or phorbol ester) or the fatty acid (glycerol phosphate) were not activators. When the negative charge was contributed by a carboxyl group (fatty acid or phosphatidylserine), stimulation of phospholipase C was weak but detectable. Structural analogs of phosphatidic acid (lipopolysaccharide, lipid A, and 2,3-diacylglucosamine 1-phosphate) were less effective but also enhanced PtdIns-P2 hydrolysis. Phosphatidic acid potentiated the activation of phospholipase C by alpha-thrombin, chelators, and guanine nucleotides. Phosphatidylinositol 4-phosphate and PtdIns-P2 were also effective activators of PtdIns-P2 degradation. Other phospholipids were without effect. The production of inositol 1,4,5-trisphosphate and diacylglycerol via the activation of phospholipase C provides a rationale for the cellular responses evoked by phosphatidic acid and the ability of this phospholipid to potentiate and initiate hormonal responses.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536532     DOI: 10.1016/0003-9861(89)90318-4

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  14 in total

1.  Platelet-derived growth factor activates phospholipase D and chemotactic responses in vascular smooth muscle cells.

Authors:  C J Welsh; K Schmeichel; K McBride
Journal:  In Vitro Cell Dev Biol       Date:  1991-05

2.  Increased phospholipase D activity in human breast cancer.

Authors:  N Uchida; S Okamura; Y Nagamachi; S Yamashita
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

3.  Regulation of ligand binding to glycoprotein IIb-IIIa (integrin alpha IIb beta 3) in isolated platelet membranes.

Authors:  S S Smyth; L V Parise
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

4.  Accumulation of phosphatidic acid mass and increased de novo synthesis of glycerolipids in platelet-activating-factor-activated human neutrophils.

Authors:  J Tou; J R Jeter; C P Dola; S Venkatesh
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

Review 5.  Phospholipase C and D regulation of Src, calcium release and membrane fusion during Xenopus laevis development.

Authors:  Bradley J Stith
Journal:  Dev Biol       Date:  2015-03-05       Impact factor: 3.582

6.  G Protein Activation Stimulates Phospholipase D Signaling in Plants.

Authors:  T. Munnik; S. A. Arisz; T. De Vrije; A. Musgrave
Journal:  Plant Cell       Date:  1995-12       Impact factor: 11.277

7.  Time-course changes in content and fatty acid composition of phosphatidic acid from rat thymocytes during concanavalin A stimulation.

Authors:  S el Bawab; O Macovschi; M Lagarde; A F Prigent
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

8.  Membrane-associated diacylglycerol kinase activity is increased by noradrenaline, but not by angiotensin II, in arterial smooth muscle.

Authors:  J Ohanian; A M Heagerty
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

9.  Vasopressin stimulates phospholipase D activity against phosphatidylcholine in vascular smooth muscle cells.

Authors:  C J Welsh; K Schmeichel; H T Cao; H Chabbott
Journal:  Lipids       Date:  1990-11       Impact factor: 1.880

10.  Phosphatidic acid as a second messenger in human polymorphonuclear leukocytes. Effects on activation of NADPH oxidase.

Authors:  D E Agwu; L C McPhail; S Sozzani; D A Bass; C E McCall
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.